Valuation: Medtronic plc

Market Cap 119B 106B 97.93B 88.73B 166B 11,287B 169B 1,168B 469B 5,937B 446B 437B 18,725B P/E 2027 *
20.9x
P/E 2028 * 19.1x
Enterprise Value 140B 125B 115B 104B 195B 13,290B 199B 1,375B 552B 6,991B 525B 514B 22,047B EV / Sales 2027 *
3.59x
EV / Sales 2028 * 3.42x
Free-Float
99.65%
Yield 2027 *
2.92%
Yield 2028 * 3.12%
1 day-1.40%
1 week-0.05%
Current month+11.88%
1 month+10.85%
3 months+10.28%
6 months+21.63%
Current year+0.50%
1 week 93.04
Extreme 93.0401
98.09
1 month 85.22
Extreme 85.22
98.09
Current year 73.31
Extreme 73.31
105.5
1 year 73.31
Extreme 73.31
106.33
3 years 69.32
Extreme 69.32
106.33
5 years 68.84
Extreme 68.84
124.63
10 years 68.84
Extreme 68.84
135.89
Manager TitleAgeSince
Chief Executive Officer 56 2020-04-26
President - 2026-10-13
Director of Finance/CFO 56 2025-03-02
Director TitleAgeSince
Director/Board Member 66 2015-01-25
Director/Board Member 64 2012-12-31
Director/Board Member 70 2014-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
10/15/26 Sell

EVP, Pres MedSurg and Americas

-10,420 0.0008%
10/15/26 Sell

Chief Executive Officer

-50,000 0.0039%
9/16/26 Sell

Executive/Senior Manager

-1,483 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.59%-0.05%+5.24%+39.05% 119B
+1.56%+3.60%-14.65%+14.38% 181B
-6.38%-4.96%-21.03%+11.44% 120B
+3.42%+4.04%-42.10%+9.69% 91.44B
+0.09%-2.26%-0.70%+76.32% 63.07B
-0.46%-0.64%+9.87%+80.82% 55.8B
-0.23%-1.27%+9.01%-21.35% 54.03B
-4.30%-2.74%-12.18%+40.84% 45.38B
+0.58%+2.18%-0.54%-6.40% 34.37B
+2.95%+5.07%+20.70%-7.84% 30.16B
Average -0.41%+0.64%-4.64%+23.69% 79.36B
Weighted average by Cap. -0.55%+0.81%-9.26%+24.02%

Financials

2027 *2028 *
Net sales 38.97B 34.9B 32.1B 29.09B 54.38B 3,700B 55.39B 383B 154B 1,946B 146B 143B 6,139B 40.4B 36.18B 33.28B 30.16B 56.37B 3,836B 57.42B 397B 159B 2,018B 152B 148B 6,363B
Net income 6.04B 5.41B 4.98B 4.51B 8.43B 574B 8.59B 59.35B 23.82B 302B 22.67B 22.19B 952B 6.51B 5.83B 5.36B 4.86B 9.08B 618B 9.25B 63.91B 25.66B 325B 24.42B 23.9B 1,025B
Net Debt 21.09B 18.89B 17.37B 15.74B 29.43B 2,003B 29.98B 207B 83.17B 1,053B 79.15B 77.47B 3,322B 19.18B 17.18B 15.8B 14.32B 26.77B 1,822B 27.27B 188B 75.65B 958B 71.99B 70.46B 3,022B
Projected Income Statement - Annual - Medtronic plc
Logo Medtronic plc
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (24.2%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (20.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.8%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - cranial and spinal technologies (14.4%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - diabetes management (8.6%): internal and external glycemia monitoring systems and insulin pumps; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - neurological disorders (5.7%): neurostimulation and pumped medication administration products, diagnostic tools, etc. ; - other (0.5%). Net sales are distributed geographically as follows: Ireland (0.4%), the United States (49.8%) and other (49.8%).
Employees
95,000
Date Price Change Volume
26-10-30 US$96.54 -0.59% 8,680,755
26-10-29 US$97.11 +2.46% 9,375,742
26-10-28 US$94.78 +0.88% 9,579,104
26-10-27 US$93.95 -0.89% 5,454,325
26-10-26 US$94.79 -0.65% 8,464,533
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Medtronic plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
97.11USD
Average target price
104.62USD
Spread / Average Target
+7.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Medtronic plc